| Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis M Nagler, LM Bachmann, H Ten Cate, A ten Cate-Hoek Blood, The Journal of the American Society of Hematology 127 (5), 546-557, 2016 | 155 | 2016 |
| Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19-a Swiss consensus statement by the Working Party Hemostasis A Casini, L Alberio, A Angelillo-Scherrer, P Fontana, B Gerber, L Graf, ... Swiss medical weekly 150, w20247, 2020 | 125 | 2020 |
| Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings S Jegerlehner, F Suter-Riniker, P Jent, P Bittel, M Nagler International Journal of Infectious Diseases 109, 118-122, 2021 | 113 | 2021 |
| Fondaparinux–data on efficacy and safety in special situations M Nagler, M Haslauer, WA Wuillemin Thrombosis research 129 (4), 407-417, 2012 | 99 | 2012 |
| A case of EDTA-dependent pseudothrombocytopenia: simple recognition of an underdiagnosed and misleading phenomenon M Nagler, P Keller, D Siegrist, L Alberio BMC Clinical Pathology 14, 1-4, 2014 | 84 | 2014 |
| Cangrelor, tirofiban, and chewed or standard prasugrel regimens in patients with st-segment–elevation myocardial infarction: primary results of the FABOLUS-FASTER trial G Gargiulo, G Esposito, M Avvedimento, M Nagler, P Minuz, G Campo, ... Circulation 142 (5), 441-454, 2020 | 75 | 2020 |
| Clinical and laboratory tests for the diagnosis of heparin-induced thrombocytopenia M Nagler, T Bakchoul Thrombosis and haemostasis 116 (11), 823-834, 2016 | 64 | 2016 |
| Heparin-induced thrombocytopenia in cardiac surgery patients AM Pishko, A Cuker Seminars in thrombosis and hemostasis 43 (07), 691-698, 2017 | 62 | 2017 |
| Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: normal values and variability S Calzavarini, J Brodard, C Quarroz, L Maire, R Nützi, J Jankovic, ... Research and practice in thrombosis and haemostasis 3 (4), 758-768, 2019 | 54 | 2019 |
| Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders M Adler, J Kaufmann, L Alberio, M Nagler Journal of thrombosis and haemostasis 17 (7), 1104-1112, 2019 | 54 | 2019 |
| Thromboembolism in patients with congenital afibrinogenaemia M Nagler, JAK Hovinga, L Alberio, K Peter-Salonen, H von Tengg-Kobligk, ... Thrombosis and haemostasis 116 (10), 722-732, 2016 | 46 | 2016 |
| Prospective evaluation of the interobserver reliability of the 4Ts score in patients with suspected heparin‐induced thrombocytopenia M Nagler, T Fabbro, WA Wuillemin Journal of Thrombosis and Haemostasis 10 (1), 151-152, 2012 | 45 | 2012 |
| Impact of changes in haematocrit level and platelet count on thromboelastometry parameters M Nagler, S Kathriner, LM Bachmann, WA Wuillemin Thrombosis Research 131 (3), 249-253, 2013 | 41 | 2013 |
| Impact of rivaroxaban on point-of-care assays P Fontana, L Alberio, A Angelillo-Scherrer, LM Asmis, W Korte, A Mendez, ... Thrombosis research 153, 65-70, 2017 | 40 | 2017 |
| Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study M Nagler, LM Bachmann, P Schmid, P Raddatz Müller, WA Wuillemin PloS one 9 (4), e95761, 2014 | 38 | 2014 |
| Accuracy of serological testing for SARS‐CoV‐2 antibodies: first results of a large mixed‐method evaluation study D Brigger, MP Horn, LF Pennington, AE Powell, D Siegrist, B Weber, ... Allergy 76 (3), 853-865, 2021 | 37 | 2021 |
| Association of anemia and hemoglobin decrease during acute stroke treatment with infarct growth and clinical outcome S Bellwald, R Balasubramaniam, M Nagler, MS Burri, SDA Fischer, ... PloS one 13 (9), e0203535, 2018 | 37 | 2018 |
| Epistaxis in anticoagulated patients: fewer hospital admissions and shorter hospital stays on rivaroxaban compared to phenprocoumon TC Sauter, K Hegazy, WE Hautz, G Krummrey, ME Ricklin, M Nagler, ... Clinical Otolaryngology 43 (1), 103-108, 2018 | 36 | 2018 |
| Comparative effectiveness and safety of anticoagulants for the treatment of heparin‐induced thrombocytopenia H Nilius, J Kaufmann, A Cuker, M Nagler American journal of hematology 96 (7), 805-815, 2021 | 35 | 2021 |
| A universal anti‐Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validation G Willekens, JD Studt, A Mendez, L Alberio, P Fontana, WA Wuillemin, ... British journal of haematology 193 (6), 1203-1212, 2021 | 33 | 2021 |
Lucas M. Bachmannmedignition Inc.在 medignition.ch 的电子邮件经过验证
